VN
Vimalkumar Natverlal Patel
About Vimalkumar Natverlal Patel
Data last updated:
Vimalkumar Natverlal Patel is a Whole-Time Director at Maitreya Medicare Limited (since 2019), Director at Torin Pharmaceuticals Private Limited (since 2021) and Director at Maitreya Lifescience Private Limited (since 2019), and holds 2 more current directorships. The companies operate in Healthcare and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹52.04 Cr; the largest is Maitreya Medicare Limited at ₹47.23 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maitreya Medicare Limited L24290GJ2019PLC107298 | Whole-Time Director | 27 May 2019 | 2019 | ₹47.23 Cr (FY 2025) | Active |
| Torin Pharmaceuticals Private Limited U24290MH2021PTC361918 | Director | 10 Jun 2021 | 2021 | ₹3.34 Cr (FY 2025) | Active |
| Maitreya Lifescience Private Limited U85320GJ2019PTC108995 | Director | 08 Jul 2019 | 2019 | ₹1.33 Cr (FY 2025) | Active |
| Maitreya Hospital Private Limited U85100GJ2021PTC119325 | Director | 06 Jan 2021 | 2021 | ₹14.1 Lakh (FY 2025) | Active |
| Vividh Health Private Limited U86909GJ2026PTC173903 | Director | 20 Feb 2026 | 2026 | Active |
Board colleagues of Vimalkumar Natverlal Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abha Surana | 10017944 | Maitreya Medicare Limited | Director |
| Hardik Vikrambhai Patel | 05338649 | Maitreya Medicare Limited | Director |
| Narendra Singh Tanwar | Maitreya Medicare Limited | Cfo | |
| Narendra Singh Tanwar | 08459007 | Maitreya Medicare Limited , Torin Pharmaceuticals Private Limited and 2 more | Managing Director |
| Girish Surajmal Pokharna | 00310761 | Torin Pharmaceuticals Private Limited | Director |
| Parimal Arvindbhai Desai | 09532104 | Torin Pharmaceuticals Private Limited | Director |
| Pranav Rohitbhai Thaker | 07602708 | Torin Pharmaceuticals Private Limited , Maitreya Lifescience Private Limited and 1 more | Director |
| Yoginiben Bhavinbhai Patel | 09199267 | Torin Pharmaceuticals Private Limited | Director |
| Hemant Tiwari | 03477652 | Vividh Health Private Limited | Director |
| Jatin Rameshchandra Joshi | 11205838 | Vividh Health Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vimalkumar Natverlal Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vimalkumar Natverlal Patel
Vimalkumar Natverlal Patel currently holds 5 directorships: Maitreya Medicare Limited (Whole-Time Director, since 27 May 2019, revenue ₹47.23 Cr (FY 2025)); Torin Pharmaceuticals Private Limited (Director, since 10 Jun 2021, revenue ₹3.34 Cr (FY 2025)); Maitreya Lifescience Private Limited (Director, since 08 Jul 2019, revenue ₹1.33 Cr (FY 2025)); Maitreya Hospital Private Limited (Director, since 06 Jan 2021, revenue ₹14.1 Lakh (FY 2025)); Vividh Health Private Limited (Director, since 20 Feb 2026).
Vimalkumar Natverlal Patel was first appointed on 27 May 2019 as Whole-Time Director at Maitreya Medicare Limited. The most recent appointment on record is 20 Feb 2026 at Vividh Health Private Limited.
The 4 current companies of Vimalkumar Natverlal Patel that report revenue have a combined latest revenue of ₹52.04 Cr: Maitreya Medicare Limited ₹47.23 Cr (FY 2025); Torin Pharmaceuticals Private Limited ₹3.34 Cr (FY 2025); Maitreya Lifescience Private Limited ₹1.33 Cr (FY 2025); Maitreya Hospital Private Limited ₹14.1 Lakh (FY 2025).
The current boards of Vimalkumar Natverlal Patel's companies include Abha Surana (Maitreya Medicare Limited), Hardik Vikrambhai Patel (Maitreya Medicare Limited), Narendra Singh Tanwar (Maitreya Medicare Limited), Narendra Singh Tanwar (Maitreya Medicare Limited), Girish Surajmal Pokharna (Torin Pharmaceuticals Private Limited), Parimal Arvindbhai Desai (Torin Pharmaceuticals Private Limited), among others.